{
     "PMID": "10681354",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20000403",
     "LR": "20140615",
     "IS": "0066-4804 (Print) 0066-4804 (Linking)",
     "VI": "44",
     "IP": "3",
     "DP": "2000 Mar",
     "TI": "Gemifloxacin is effective in experimental pneumococcal meningitis.",
     "PG": "767-70",
     "AB": "In a rabbit model of Streptococcus pneumoniae meningitis, 5 mg of gemifloxacin mesylate (SB-265805) per kg/h reduced the bacterial titers in cerebrospinal fluid (CSF) almost as rapidly as 10 mg of ceftriaxone per kg/h (Deltalog CFU/ml/h +/- standard deviation [SD], -0.25 +/- 0.09 versus -0.38 +/- 0.11; serum and CSF concentrations of gemifloxacin were 2.1 +/- 1.4 mg/liter and 0.59 +/- 0.38 mg/liter, respectively, at 24 h). Coadministration of 1 mg of dexamethasone per kg did not affect gemifloxacin serum and CSF levels (2.7 +/- 1.4 mg/liter and 0.75 +/- 0.34 mg/liter, respectively, at 24 h) or activity (Deltalog CFU/ml/h +/- SD, -0.26 +/- 0.11).",
     "FAU": [
          "Smirnov, A",
          "Wellmer, A",
          "Gerber, J",
          "Maier, K",
          "Henne, S",
          "Nau, R"
     ],
     "AU": [
          "Smirnov A",
          "Wellmer A",
          "Gerber J",
          "Maier K",
          "Henne S",
          "Nau R"
     ],
     "AD": "Department of Neurology, University of Gottingen, Gottingen, Germany.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "United States",
     "TA": "Antimicrob Agents Chemother",
     "JT": "Antimicrobial agents and chemotherapy",
     "JID": "0315061",
     "RN": [
          "0 (Anti-Infective Agents)",
          "0 (Cephalosporins)",
          "0 (Fluoroquinolones)",
          "0 (Naphthyridines)",
          "75J73V1629 (Ceftriaxone)",
          "OKR68Y0E4T (gemifloxacin)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Anti-Infective Agents/pharmacokinetics/*therapeutic use",
          "Ceftriaxone/therapeutic use",
          "Cephalosporins/therapeutic use",
          "Cerebrospinal Fluid/immunology/microbiology",
          "Disease Models, Animal",
          "*Fluoroquinolones",
          "Hippocampus/pathology",
          "Meningitis, Pneumococcal/*drug therapy/microbiology/pathology",
          "Microbial Sensitivity Tests",
          "Naphthyridines/pharmacokinetics/*therapeutic use",
          "Neurons/pathology",
          "Rabbits",
          "Streptococcus pneumoniae/isolation & purification"
     ],
     "PMC": "PMC89762",
     "EDAT": "2000/02/19 00:00",
     "MHDA": "2000/02/19 00:01",
     "CRDT": [
          "2000/02/19 00:00"
     ],
     "PHST": [
          "2000/02/19 00:00 [pubmed]",
          "2000/02/19 00:01 [medline]",
          "2000/02/19 00:00 [entrez]"
     ],
     "PST": "ppublish",
     "SO": "Antimicrob Agents Chemother. 2000 Mar;44(3):767-70.",
     "term": "hippocampus"
}